Clinical Trials Logo

Critical Illness Myopathy clinical trials

View clinical trials related to Critical Illness Myopathy.

Filter by:

NCT ID: NCT01968889 Completed - Clinical trials for Critical Illness Myopathy

ICU Acquired Neuromyopathy and Diaphragm Function

Start date: May 2013
Phase: N/A
Study type: Observational

Critical illness neuromyopathy is a common disease acquired during ICU stay leading to a deep weakness involving the respiratory muscle work which result in a delayed weaning of mechanical ventilation. The main objective is to quantify the loss of diaphragm function by measuring the diaphragm force (using the non invasive method by phrenic nerve stimulation allowing to measure the twitch airway pressure during airway occlusion) in a selected population of patients with critical illness neuromyopathy (defined as a MRC score < 48). The second end points are to evaluate its incidence, the consequences on the patients outcome (extubation success or failure; ICU stay) and to evaluate the relations between diaphragm function (twitch airway pressure during airway occlusion, maximal inspiratory pressure and diaphragm thickness evaluated by ultrasound) and peripheral limbs force (evaluated by the Medical Research Council - MRC score).

NCT ID: NCT00976807 Completed - Clinical trials for Critical Illness Myopathy

Rehabilitation Following Critical Illness

Start date: November 2009
Phase: N/A
Study type: Interventional

The principal research question to be answered by this study is whether an exercise based rehabilitative intervention following critical illness can generate improvements in exercise capacity and quality of life beyond current (usual) care. The investigators will also aim to demonstrate that such an intervention is both practical and cost-effective.